Tiphaine shares her story after nearly a decade of living with a neuroendocrine tumor (NET) and her experience with Radioligand Therapy (RLT).
After two surgeries and years of somatostatin analogue injections, RLT was introduced as a systemic option to address disease progression. In this video, she explains, in accessible terms, how the therapy works, how targeted it is compared to traditional treatments, and the side effects she experienced.
She also describes the improvements she can feel: reduced fatigue, less pain linked to liver lesions, and an improved quality of life, and highlights the importance of being proactive, informed, and supported.
As a patient advocate, she encourages others to seek information, ask questions, and rely on foundations and patient associations when navigating NET care.
Tiphaine’s story reflects both the challenges of living with a "chronic cancer" and the hope that RLT and future innovations such as alpha-therapy can bring to patients around the world.
